techcrunch
PublishedNovember 17, 2026 at 2:50 PM
Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Publisher summary· verbatim
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
Stay posted· Newsletter
Three short emails a week: Monday, Wednesday and Friday. Top movers, new models and the most-referenced story.
Your email is used only to send The Bubble Brief. Privacy policy
Discussion
No replies yet. Be first.
Related coverage
More from TECHCRUNCH
techcrunchProton’s Lumo, a privacy-focused alternative to ChatGPT and Claude, arrives on desktop1htechcrunchAI models can be tricked into identifying civilians as military targets by telling them it’s a game1htechcrunchJensen Huang says he would be ‘honored’ if allowed to return as Nvidia CEO1htechcrunchDaydream’s new AI agent acts as your personal stylist — and can shop for you, too2hThe Bubble Brief
MON · WED · FRIRead AI insights every Monday, Wednesday and Friday — top movers, new models, story of the week.
Your email is used only to send The Bubble Brief. Privacy policy
Originally published on techcrunch ↗